SynthesisRheumatology international2021
Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?
C A Pereda et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it